Karina Vila Rivera
Rheumatology · Barceloneta, PRNPI 1497952584
Payments from drug & device makers
Across 1,025 payments — averaging $4876.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3M
- Eli Lilly Export S.A. Puerto Rico Branch$1.2M
- Janssen Research & Development, LLC$452K
- Sanofi US Services Inc.$260K
- Takeda Pharmaceuticals U.S.A., Inc.$100K
- Eli Lilly$28K
- plus $9K from 17 others
Across 35 payments — averaging $559.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$14K
- AbbVie$3K
- Sanofi US Services Inc.$2K
What the payments were for
- Consulting fees$5,25336%
- Travel & lodging$1,75512%
- Food & beverage$7,31351%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 636 | $2,992,101 |
| Eli Lilly Export S.A. Puerto Rico Branch | 25 | $1,157,928 |
| Janssen Research & Development, LLC | 59 | $451,547 |
| Sanofi US Services Inc. | 56 | $259,892 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $100,252 |
| Eli Lilly | 44 | $27,905 |
| Idorsia Pharmaceuticals US Inc | 6 | $2,750 |
| Amgen | 58 | $2,201 |
| Johnson & Johnson | 8 | $1,368 |
| Novo Nordisk | 14 | $515 |
| AstraZeneca | 11 | $508 |
| ANI Pharmaceuticals, Inc. | 18 | $394 |
| GSK | 9 | $359 |
| E.r. Squibb & Sons, L.L.C. | 21 | $333 |
| Novartis | 13 | $309 |
| PBG Puerto Rico LLC | 10 | $177 |
| Mallinckrodt Hospital Products Inc. | 1 | $85 |
| Pfizer | 1 | $79 |
| Pfizer Pharmaceuticals LLC | 1 | $25 |
| Boehringer Ingelheim | 1 | $24 |
| Organon | 1 | $24 |
| Merck | 1 | $20 |
| Radius Health, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,998,816 in reported general payments places this provider in the 95th percentile of 88 rheumatology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 164 | $1,459,644 |
| RinvoqUpadacitinib | 157 | $1,018,378 |
| Enbrel SureclickEtanercept | 80 | $588,671 |
| Xeljanz XrTofacitinib Citrate | 97 | $560,473 |
| Orencia ClickjectAbatacept | 82 | $466,546 |
| Humira PenAdalimumab | 22 | $264,100 |
| BenlystaBelimumab | 54 | $258,740 |
| OtezlaApremilast | 26 | $129,047 |
| OrenciaAbatacept | 22 | $125,247 |
| ProliaDenosumab | 54 | $95,341 |
| EnbrelEtanercept | 11 | $83,540 |
| TrulicityDulaglutide | 78 | $77,275 |
| MounjaroTirzepatide | 52 | $56,336 |
| RybelsusSemaglutide | 56 | $54,597 |
| OzempicSemaglutide | 36 | $36,750 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Savella, Synthroid | $2,992,101 | $1,036,397287 claims |
| AmgenOtezla, Prolia, Enbrel | $2,201 | $307,92791 claims |
| GSKBenlysta | $359 | $258,74054 claims |
| E.r. Squibb & Sons, L.L.C.Orencia | $333 | $125,24722 claims |
| Novo NordiskRybelsus, Ozempic | $515 | $91,34792 claims |
| Boehringer IngelheimJardiance | $24 | $14,01319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 88 rheumatology providers in Puerto Rico.
Other rheumatology in Barceloneta
- Carlos PantojasSan Juan$3.2M
- Oscar Soto RaicesSan Juan$3.1M
- Amarilis Perez de JesusCaguas$914K
- Radames Sierra ZoritaSan Juan$428K
- Paloma AlejandroSan Juan$347K
- Ramon Toro-TorresSan German$328K
- Maria Chirino-SociasSan Juan$296K
- Yvonne FontSan Juan$193K
- Jose Ramirez VazquezSan Juan$171K
- Ileana Vazquez OteroGuaynabo$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.